<i>In Vitro</i> Fertilization/Intracytoplasmic Sperm Injection with Autologous Oocytes in Healthy Women of Advanced Maternal Age: A Comparative Study Investigating Obstetric and Perinatal Outcomes Through Single Versus Double Embryo Transfer-Reference-Cited by-同舟云学术

In Vitro Fertilization/Intracytoplasmic Sperm Injection with Autologous Oocytes in Healthy Women of Advanced Maternal Age: A Comparative Study Investigating Obstetric and Perinatal Outcomes Through Single Versus Double Embryo Transfer

Published:2024-04-01 Issue:1 Volume:5 Page:512-521
ISSN:2688-4844
Container-title:Women's Health Reports
language:en
Short-container-title:Women's Health Reports

Author:

Reinolds Ellen-Elena¹²,Tsiartas Panagiotis³⁴^ORCID,Hadziosmanovic Nermin⁵,Rodriguez-Wallberg Kenny A.¹⁶

Affiliation:

1. Division of Gynecology and Reproduction, Department of Reproductive Medicine, Karolinska University Hospital, Stockholm, Sweden.

2. Department of Obstetrics and Gynecology, Södertälje Hospital, Stockholm, Sweden.

3. Nordic IVF Solna, Eugin Group, Solna, Sweden.

4. Division of Obstetrics and Gynecology, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institute, Stockholm, Sweden.

5. Clinical Research Center, Uppsala University, Uppsala, Sweden.

6. Laboratory of Translational Fertility Preservation, Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.

Publisher

Mary Ann Liebert Inc

Link

https://www.liebertpub.com/doi/pdf/10.1089/whr.2023.0178

Reference30 articles.

1. Reproduction at an advanced maternal age and maternal health

2. Caesarean section in nulliparous women of advanced maternal age has been reduced in Sweden and Norway since the 1970s: a register-based study

3. Advanced maternal age and adverse pregnancy outcomes: A systematic review and meta-analysis

4. Advanced Maternal Age and Adverse Perinatal Outcome

5. Neonatal and Maternal Composite Adverse Outcomes Among Low-Risk Nulliparous Women Compared With Multiparous Women at 39–41 Weeks of Gestation